Pfizer, Inc. Press Releases

PFE 
$29.03
*  
0.03
0.1%
Get PFE Alerts
*Delayed - data as of Feb. 5, 2016  -  Find a broker to begin trading PFE now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing



PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2015 RESULTS
2/2/2016 6:45:00 AM - Business Wire
▼-4.35 % Price Change since this news event. The Volume Ratio is 1.31.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Bristol-Myers Squibb and Pfizer Sign Collaboration with Portola Pharmaceuticals to Develop and Commercialize Investigational Andexanet Alfa in Japan
2/1/2016 6:55:00 AM - Business Wire
▼-4.63 % Price Change since this news event. The Volume Ratio is 1.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day






Philogen Announces Exercise of Options Within the License Agreement With Pfizer Inc. for the Development and Potential Commercialization of Multiple Antibody Drug Conjugates (ADCs) and Targeted Technologies
1/21/2016 9:05:00 AM - PR Newswire
▼-5.53 % Price Change since this news event. The Volume Ratio is 0.97.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day










Pfizer Acquires Treerly and Its Family of Products from Sirio Pharma
1/13/2016 7:04:00 PM - Business Wire
▼-4.44 % Price Change since this news event. The Volume Ratio is 1.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


California Institute for Biomedical Research (Calibr) enters worldwide strategic collaboration with Pfizer Inc.
1/13/2016 1:10:00 PM - PR Newswire
▼-5.96 % Price Change since this news event. The Volume Ratio is 1.71.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


ChapStick® Announces Actress Rachel Bilson as New Brand Spokesperson
1/11/2016 8:32:00 AM - Business Wire
▼-6.96 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


HemoShear Therapeutics Announces Next Stage of Safety Collaboration with Pfizer Inc.
1/11/2016 7:00:00 AM - PR Newswire
▼-6.14 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Expands R&D Equity Investment Strategy to Access Early-Stage Scientific Innovations
1/8/2016 4:13:00 PM - Business Wire
▼-6.35 % Price Change since this news event. The Volume Ratio is 1.36.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Enters into Translational Research Collaboration with Adaptive Biotechnologies to Help Advance Novel Immuno-Oncology Solutions
1/8/2016 8:00:00 AM - Business Wire
▼-7.22 % Price Change since this news event. The Volume Ratio is 1.18.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Pfizer Invites Public to Listen to Webcast of Pfizer and Allergan Discussion at 34th Annual J.P. Morgan Healthcare Conference
1/5/2016 10:00:00 AM - Business Wire
▼-9.62 % Price Change since this news event. The Volume Ratio is 1.4.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer
1/4/2016 8:00:00 AM - Business Wire
▼-8.57 % Price Change since this news event. The Volume Ratio is 2.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


KineMed Enters Into Strategic Proteomic Biomarker Discovery Collaboration with Pfizer Inc.
1/4/2016 6:00:00 AM - Business Wire
▼-9.82 % Price Change since this news event. The Volume Ratio is 2.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Pfizer Invites Public To View And Listen To Webcast Of February 2 Conference Call With Analysts
12/22/2015 10:00:00 AM - Business Wire
▼-10.65 % Price Change since this news event. The Volume Ratio is 0.56.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Merck KGaA, Darmstadt, Germany and Pfizer Advance Clinical Development Program with Two Additional Phase III Trials of Avelumab
12/22/2015 8:00:00 AM - Business Wire
▼-10.68 % Price Change since this news event. The Volume Ratio is 0.57.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




U.S. News & World Report Launches Best Stocks Rankings
12/18/2015 12:01:00 AM - PR Newswire


U.S. News & World Report Launches Best Stocks Rankings
12/18/2015 12:01:00 AM - PR Newswire



Learn more by visiting our FAQ page